Health impact assessment of a voluntary protocol to decrease salt in bread: what can we learn?
نویسندگان
چکیده
Abstract Issue Hypertension (HT) is a major and modifiable risk factor for cardiovascular diseases (CVD), which can be caused by excessive salt intake. Portugal has one of the highest mortality rate due to CVD in Europe, mainly HT. Thus, reduction intake from food products strategies advocated modify blood pressure (BP) its impact on Description problem The Portuguese population daily bread consumption. 2017 voluntary ‘Protocol' was signed between stakeholders with goal reduce content 2021. Herein, using Health Impact Assessment (HIA) approach we aimed estimate potential effect BP implementation this ‘Protocol'. two national surveys were used find average values population, while estimates calculated based upon meta-analysis data. Results It expected that could ingestion have higher effect, mostly more vulnerable populations. In fact, results showed individuals low educational level, men, aged residents South region ones benefit implementation. However, study found effects very all groups analysed, suggesting only slight health gains occur. Lessons as agreement not sufficient attain public targets devised. Following HIA framework, further complementary intersectoral integrated measures, through use compulsory fiscal policies preferably extended other highly consumed products, thus recommended. comprehensive tool assess impacts, supporting at each context design effective promote effectively prevent hypertension. Key messages systematic appropriate policy framework inform adequately political decision-making crucial Non-Communicable Diseases. Voluntary agreements should complemented measures improve efficacy aiming
منابع مشابه
Adopting New International Health Instruments – What Can We Learn From the FCTC?; Comment on “The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?”
This Commentary forms a response to Nikogosian’s and Kickbusch’s forward-looking perspective about the legal strength of international health instruments. Building on their arguments, in this commentary we consider what we can learn from the Framework Convention on Tobacco Control (FCTC) for the adoption of new legal international health instruments.
متن کاملWhat Can We Learn from 21 Years of School Poisonings in New Zealand?
Background: Childhood poisoning is a significant international health concern. Very little is known about trends in exposures within schools and preschools. The objectives of this study were to investigate the data recorded by the New Zealand National Poisons Centre (NPC) on these types of exposures over a 21 year period (1989 to 2009) and to determine trends and propose strategies to reduce th...
متن کاملImpact factor statistics and publication practice: What can we learn?
In scientific publishing, one measure has developed into a universal remedy. The Journal Citation Reports (JCR) compiled from scientific literature in the ISI database by Thomson Scientific provide a shorthand measure of scientific success. The logic behind this is compelling. Science proceeds through communication. If scientific insight is not noticed, the effort was wasted. If it is noticed, ...
متن کاملThe French Health Care System; What can We Learn?
All public systems look for the best organizational structure to funnel part of their national income into healthcare services. Appropriate policies may differ widely across country settings. Most healthcare systems fall under one of two broad categories, either Bismark or Beveridge systems. There is no simple ideal model for the organization of health services, but most healthcare systems that...
متن کاملWhat Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?
Background The unregulated availability and irrational use of tuberculosis (TB) medicines is a major issue of public health concern globally. Governments of many low- and middle-income countries (LMICs) have committed to regulating the quality and availability of TB medicines, but with variable success. Regulation of TB medicines remains an intractable challenge in many settings, but the reason...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European journal of public health
سال: 2021
ISSN: ['1101-1262', '1464-360X']
DOI: https://doi.org/10.1093/eurpub/ckab165.307